Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Capital/Financing Update 2007

Aug 28, 2007

65022_rns_2007-08-28_676654d8-7756-41f5-905d-995c6c3c67df.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [562 x 65] intentionally omitted <==

==> picture [562 x 66] intentionally omitted <==

ASX ANNOUNCEMENT

August 29[th] , 2007


GTG Grants Further License to Monsanto

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report it has now granted Monsanto Company, based in St. Louis, Missouri, USA, a further license, this time for applications of the GTG non-coding patents to swine.

In June 2007, GTG reported to ASX it had granted a first license to Monsanto for applications in plants. That first license was part of a legal settlement of various past disagreements between GTG and Monsanto, at which time Monsanto also paid GTG US$5 million in cash. Monsanto now pays GTG a further US$1 million. The other terms of this legal settlement between GTG and Monsanto are covered by corporate confidentiality and cannot be disclosed.

The parties have also agreed to explore additional ways of working together.

GTG will provide further details to the Market, as appropriate.


FOR FURTHER INFORMATION PLEASE CONTACT

Dr. Mervyn Jacobson Chief Executive Officer

Genetic Technologies Limited Phone: +61 3 9415 1135

Genetic Technologies LimitedWebsite : www.gtg.com.auEmail : [email protected] ABN 17 009 212 328 Registered Office • 60-70 Hanover Street Fitzroy VIC 3065 Australia • Postal Address P.O. Box 115 Fitzroy Victoria 3065 Australia Phone 61 3 9415 1135 • Fax 61 3 9417 2987